Login

A Financial Analyst at SilverStone Group, Inc., holding a Chemistry bachelor's degree and an MBA from Creighton University. 00:10:00

Share On Facebook Share On Twitter

Karan Keith Agarwal - Founder | CEO - Silverstone Group

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Doug Lopez of Aristotle Credit Partners Discusses the Future of ESG Investing
00:10:00
Rodney Managing Half a Trillion: Navigating Market Uncertainty with Voya | Rodney O. Martin, Jr., CEO , Voya Financial.
00:10:00
Peter Podesser Presents SFC Energy's Role in Advancing Fuel Cell Technology for Clean Energy Solutions.
00:10:00
Defense Technology Parent Cohort (AIM: CHRT): Innovating for UK and Global Markets | Andrew Thomis - CEO of cohort plc
00:10:00
Navigating Financial Distress and Uncertainty in M&A
00:10:00
Supercharges you to go from zero to one quickly|Erik Torenberg,Co-Founder & Partner,Village Global
00:10:00
open a development models that stimulate communication|Greg Papadopoulos,Venture Partner,New Enterprise Associates (NEA)
00:10:00
Financial Analysis of ContourGlobal: A Deep Dive into Their Profit Margins and Earnings
00:10:00
Lawrence Stroll Outlines Aston Martin's Ambitious Future | Lawrence Stroll, Chairman, Lawrence Stroll Aston Martin Lagonda Global Holdings PLC.
00:10:00
Salazar Resources: Ecuadorian Copper Exploration
00:10:00
Capitalizing on Mining Opportunities: Caffeine Minerals at the One-to-One Mining Investment Conference
00:10:00
Exploring Water Management Futures: Insights from the 8th Annual Conference in Delphi | Harry Sachinis, CEO, Athens Water Supply and Sewerage Company.

© 2017 - Neuhu+